Title:
GENETIC MARKER FOR PREDICTING CONCENTRATION OF STATIN DRUG IN BLOOD
Document Type and Number:
WIPO Patent Application WO/2020/060211
Kind Code:
A1
Abstract:
The present invention relates to a genetic marker for predicting the concentration of a statin drug in blood. The genetic marker for predicting a blood statin concentration according to the present invention can predict, with high accuracy, a group with a blood statin concentration that is higher or lower than that of a normal group even when statin is injected at the same concentration, and thus can be usefully applied to determine the amount of statin to be injected.
Inventors:
CHO EUN-HAE (KR)
JANG JA-HYUN (KR)
JEON YOUNG-JOO (KR)
LEE TAEHEON (KR)
JANG JA-HYUN (KR)
JEON YOUNG-JOO (KR)
LEE TAEHEON (KR)
Application Number:
PCT/KR2019/012111
Publication Date:
March 26, 2020
Filing Date:
September 19, 2019
Export Citation:
Assignee:
GREEN CROSS GENOME CORP (KR)
International Classes:
C12Q1/6876; G01N33/53
Foreign References:
| US20120040347A1 | 2012-02-16 | |||
| US20070202518A1 | 2007-08-30 | |||
| US20160040239A1 | 2016-02-11 | |||
| US20140005281A1 | 2014-01-02 | |||
| CN106987618A | 2017-07-28 | |||
| KR101099615B1 | 2011-12-29 |
Other References:
DATABASE NCBI 9 July 2019 (2019-07-09), Database accession no. rs72655363
DATABASE NCBI 9 July 2019 (2019-07-09), Database accession no. rs15524
DATABASE NCBI 9 July 2019 (2019-07-09), Database accession no. rs15524
Attorney, Agent or Firm:
LEE, Cheo Young et al. (KR)
Download PDF: